(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Spatial Proteomics market - Global industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.
The Spatial Proteomics Market was valued at USD 92.40 Million in 2024, and is expected to reach USD 189.25 Million by 2030, rising at a CAGR of 12.65%. The global spatial proteomics market is experiencing rapid growth, driven by advancements in technology and the increasing demand for precise biological insights.
Key factors fueling market growth include the integration of high-resolution imaging techniques, mass spectrometry advancements, and artificial intelligence in data analysis. As pharmaceutical and biotechnology companies focus on precision medicine, spatial proteomics plays a critical role in identifying biomarkers and therapeutic targets. However, challenges such as high costs, technical complexities, and limited standardization remain. Despite this, the market is expected to expand significantly, driven by ongoing research and innovation.
Market Drivers Advancements in Mass Spectrometry Technologies Growing Demand for Precision Medicine Technological Integration with Imaging Platforms Increasing Investment in Life Sciences Research Rising Prevalence of Chronic Diseases
Market Challenges
High Costs and Accessibility Technical Complexity and Lack of Standardization
Market Trends
Expanding Applications in Drug Discovery and Development Advancements in Data Analytics & AI Integration
North America is currently the dominant region. The region leads in terms of market share, driven by several factors including substantial investments in life sciences research, the presence of top pharmaceutical and biotechnology companies, and advanced academic research institutions. North America, particularly the United States, is home to some of the world's leading research centers, hospitals, and biotechnology firms, all of which are heavily involved in the adoption and development of spatial proteomics technologies.
The United States has long been at the forefront of proteomics research and development, contributing significantly to the market's growth. The country benefits from a strong ecosystem of both public and private sector funding, with major government agencies such as the National Institutes of Health (NIH) and the National Science Foundation (NSF) supporting research in proteomics and related fields. The federal funding allocated to proteomics research drives innovations in spatial proteomics, allowing for the development of cutting-edge technologies and increasing their adoption across various sectors. The presence of a well-established healthcare infrastructure and biotechnology companies ensures that spatial proteomics technologies are integrated into clinical research and therapeutic development.
North America is also home to numerous leading pharmaceutical and biotechnology companies that use spatial proteomics to enhance drug discovery, precision medicine, and therapeutic development. The integration of spatial proteomics into R&D pipelines allows these companies to develop targeted treatments, particularly in areas such as oncology, neurology, and immunology, where protein localization plays a critical role in disease progression and therapy development. With large-scale investments in biotechnology, drug discovery, and personalized medicine, these companies are driving the adoption of spatial proteomics in the region.
Key Players Profiled in the Spatial Proteomics Market
10x Genomics, Inc. Bruker Corporation Standard BioTools Inc. Bruker Spatial Biology, Inc. Akoya Biosciences, Inc. PerkinElmer, Inc. Danaher Corporation Bio-Techne Corporation S2 Genomics, Inc. Seven Bridges Genomics Inc.
Report Scope
Spatial Proteomics Market, By Product:
Instruments Consumables Software
Spatial Proteomics Market, By Technology:
Imaging-based Technologies Mass Spectrometry-based Technologies Sequencing-based Technologies Others
Spatial Proteomics Market, By Workflow:
Sample Preparation Instrumental Analysis Data Analysis
Spatial Proteomics Market, By Sample Type:
Spatial Proteomics Market, By End Use:
Academic & Translational Research Institutes Pharmaceutical & Biotechnology Companies Others
Spatial Proteomics Market, By Region:
North America United States Canada Mexico
Europe France United Kingdom Italy Germany Spain
Asia-Pacific China India Japan Australia South Korea
South America Brazil Argentina Colombia
Middle East & Africa South Africa Saudi Arabia UAE
Key Attributes
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment